Robert J. Fram

Robert J.
Fram is Chief Medical Officer of Mersana Therapeutics, Inc. Most recently, Dr. Fram was Vice President of Clinical Development for ImmunoGen.
Prior to ImmunoGen, he worked with Vertex Pharmaceuticals, Ilex Oncology, and Knoll Pharmaceuticals.
Dr. Fram was a Principal at Dana Farber Cancer Institute and Harvard Medical School and as an Associate Professor of Medicine at the University of Massachusetts Medical School and at the University of Maryland Cancer Center.
He was a Clinical Associate Professor of Medicine at the Brown University Medical School.
Dr. Fram has 28 years of experience in medical oncology.
He received an AB degree from Harvard College in 1971 and an MD from Harvard Medical School in 1976.
Dr. Fram completed his Post-Doctoral Training in Internal Medicine at Columbia Presbyterian Medical Center and in Hematology and Oncology at Dana Farber Cancer Institute and Brigham and Women's Hospital in Boston.